Where do NewAmsterdam Pharma Company's ratios come from?

Every ratio is computed from NewAmsterdam Pharma Company's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-953.6%+49.3pp	-1,002.9%-427pp	-575.8%-306pp	-270%+133pp	-402.5%-15.6pp
Net margin	-942.8%-37.0pp	-905.7%-278pp	-627.3%-368pp	-258.9%+139pp	-397.5%+133pp
Returns
Return on equity	-29.5%-1.2pp	-28.3%+11.7pp	-39.9%-11.5pp	-28.4%+3.1pp	-31.5%+14.7pp
Return on invested capital	-181.6%—	——	——	——	——
Efficiency
Asset turnover	0×0.0×	0×0.0×	0.1×0.0×	0.1×0.0×	0.1×0.0×
Liquidity
Current ratio	9.8×+1.9×	7.9×-4.7×	12.6×-8.5×	21.1×+1.1×	20×+11.9×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Valuation
Market capitalization	$3.68B-7.5%	$3.98B+24.2%	$3.2B+55.1%	$2.07B-8.1%	$2.25B-18.3%
Price / sales	163.1×-13.7×	176.8×+85.9×	90.9×+58.6×	32.3×-15.4×	47.7×-12.7×
Price / book	5.5×-0.3×	5.8×+1.4×	4.4×+1.7×	2.7×-0.2×	2.9×-0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do NewAmsterdam Pharma Company's ratios come from?: Every ratio is computed from NewAmsterdam Pharma Company's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.